(Q69609528)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

title

Preferential homing of tumor-infiltrating lymphocytes in tumor-bearing mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

author name string

I H Ames

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

G M Gagne

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

A M Garcia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

P A John

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

G M Scatorchia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

R H Tomar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

J G McAfee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

4 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

page(s)

93-100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2720709%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00199283

4 October 2019

exact match

0 references

cites work

Immunohistological analysis of lymphocyte subpopulations infiltrating breast carcinomas and benign lesions

1 reference

12 December 2020

Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer

1 reference

12 December 2020

Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study

1 reference

12 December 2020

Immunotherapy of cancer using interleukin 2: current status and future prospects

1 reference

12 December 2020

Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity

1 reference

12 December 2020

Passive Immunotherapy of Cancer in Animals and Man

1 reference

12 December 2020

Generation of lymphokine-activated killer (LAK) cells from tumor-infiltrating lymphocytes

1 reference

12 December 2020

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

12 December 2020

Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.

1 reference

12 December 2020

In vivo and in vitro effect of adoptive immunotherapy of experimental murine brain tumors using lymphokine-activated killer cells

1 reference

12 December 2020

Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients.

1 reference

12 December 2020

Adoptive immunotherapy of cancer: accomplishments and prospects

1 reference

12 December 2020

Ultrastructural analysis of human natural killer cell activation.

1 reference

12 December 2020

Cytotoxicity by natural killer cells: analysis of large granular lymphocytes

1 reference

12 December 2020

Effect of lymphokine-activated killer cell fraction on the development of human hematopoietic progenitor cells

1 reference

12 December 2020

Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas

1 reference

12 December 2020

Migratory patterns of different indium-111 labeled leukocyte populations (chiefly lymphocytes) from control and thymectomized rats

1 reference

12 December 2020

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

12 December 2020

In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties

1 reference

12 December 2020

Modification of natural killer activity of lymphocytes infiltrating human lung cancers.

1 reference

12 December 2020

Mechanisms of natural cell-mediated resistance in human solid tumors

1 reference

12 December 2020

Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes

1 reference

12 December 2020

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

1 reference

12 December 2020

Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes (LGL)

1 reference

12 December 2020

Natural killer activity of lymphocytic infiltrates in mouse mammary lesions

1 reference

12 December 2020

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

1 reference

12 December 2020

Adoptive immunotherapy of malignant diseases with IL-2-activated lymphocytes

1 reference

12 December 2020

Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome

1 reference

12 December 2020

A rapid method for the isolation of functional thymus-derived murine lymphocytes

1 reference

12 December 2020

Functional analysis of mononuclear cells infiltrating into tumors. III. Soluble factors involved in the regulation of T lymphocyte infiltration into tumors

1 reference

12 December 2020

Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor

1 reference

12 December 2020

The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy

1 reference

12 December 2020

Characterization of lymphocytic infiltrates in normal, preneoplastic, and neoplastic mouse mammary tissues

1 reference

12 December 2020

Simultaneous development of cells with large granular lymphocyte (LGL) morphology and natural killer (NK) cell lytic activity after bone marrow (BM) transplantation in mice

1 reference

12 December 2020

Progressive Loss of H-2 Antigens With Concomitant Increase of Cell-Surface Antigen(s) Determined by Moloney Leukemia Virus in Cultured Murine Lymphomas23

1 reference

12 December 2020

Lysosome rich cells contain the lytic activity of lymphokine-activated killer cell populations

1 reference

12 December 2020

Isolation and reactivity of host effectors associated with the manifestation of concomitant tumor immunity

1 reference

12 December 2020

Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma

1 reference

12 December 2020

Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin

1 reference

12 December 2020

Natural killer activity in the rat. IV. Distribution of large granular lymphocytes (LGL) following intravenous and intraperitoneal transfer

1 reference

12 December 2020

Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.

1 reference

12 December 2020

Phenotypic characterization of murine lymphokine-activated killer cells

1 reference

12 December 2020

The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors

1 reference

12 December 2020

Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes

1 reference

12 December 2020

Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells

1 reference

12 December 2020

Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2

1 reference

12 December 2020